Loading
Latest filing published 01 Jun 2011 for POLYMEDIX INC, €4,505.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Brian Anderson discloses dealings in 2 companies, chiefly Oragenics Inc and Polymedix Inc. The record holds 3 filings, for trades running from 3 October 2005 to 31 May 2011.
In open-market terms, that means 1 purchase worth €4,505 on one side and 2 sales worth €1,812 on the other. Netting one side against the other leaves €2,693 of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2011 alone, the filings show 1 purchase and no sales.
Most recently, on 1 June 2011, the filings show an open-market purchase worth €4,505 in Polymedix Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations